These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25283972)

  • 21. Iron oxide/manganese oxide co-loaded hybrid nanogels as pH-responsive magnetic resonance contrast agents.
    Wang X; Niu D; Wu Q; Bao S; Su T; Liu X; Zhang S; Wang Q
    Biomaterials; 2015; 53():349-57. PubMed ID: 25890733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging--initial findings.
    Stadnik TW; Everaert H; Makkat S; Sacré R; Lamote J; Bourgain C
    Eur Radiol; 2006 Oct; 16(10):2153-60. PubMed ID: 16670863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MR imaging of head and neck tumors: comparison of T1-weighted contrast-enhanced fat-suppressed images with conventional T2-weighted and fast spin-echo T2-weighted images.
    Ross MR; Schomer DF; Chappell P; Enzmann DR
    AJR Am J Roentgenol; 1994 Jul; 163(1):173-8. PubMed ID: 8010208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Squamous cell carcinoma of the oral cavity: MR findings and value of T1-versus T2-weighted fast spin-echo images.
    Yasumoto M; Shibuya H; Takeda M; Korenaga T
    AJR Am J Roentgenol; 1995 Apr; 164(4):981-7. PubMed ID: 7726062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Redoxable heteronanocrystals functioning magnetic relaxation switch for activatable T1 and T2 dual-mode magnetic resonance imaging.
    Kim MH; Son HY; Kim GY; Park K; Huh YM; Haam S
    Biomaterials; 2016 Sep; 101():121-30. PubMed ID: 27281684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hybrid lanthanide nanoparticles as a new class of binary contrast agents for in vivo T
    Yi Z; Li X; Lu W; Liu H; Zeng S; Hao J
    J Mater Chem B; 2016 Apr; 4(15):2715-2722. PubMed ID: 32263296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the accuracy of PET/CT and PET/MRI spatial registration of multiple metastatic lesions.
    Rakheja R; DeMello L; Chandarana H; Glielmi C; Geppert C; Faul D; Friedman KP
    AJR Am J Roentgenol; 2013 Nov; 201(5):1120-3. PubMed ID: 24147486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-contrast magnetic resonance imaging for monitoring patients with acoustic neuroma.
    Forgues M; Mehta R; Anderson D; Morel C; Miller L; Sevy A; Son L; Arriaga M
    J Laryngol Otol; 2018 Sep; 132(9):780-785. PubMed ID: 30117408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of Ferromagnetic Fe0.6 Mn0.4 O Nanoflowers as a New Class of Magnetic Theranostic Platform for In Vivo T1 -T2 Dual-Mode Magnetic Resonance Imaging and Magnetic Hyperthermia Therapy.
    Liu XL; Ng CT; Chandrasekharan P; Yang HT; Zhao LY; Peng E; Lv YB; Xiao W; Fang J; Yi JB; Zhang H; Chuang KH; Bay BH; Ding J; Fan HM
    Adv Healthc Mater; 2016 Aug; 5(16):2092-104. PubMed ID: 27297640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The advantage of high relaxivity contrast agents in brain perfusion.
    Cotton F; Hermier M
    Eur Radiol; 2006 Nov; 16 Suppl 7():M16-26. PubMed ID: 18655263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Redox-Sensitive Clustered Ultrasmall Iron Oxide Nanoparticles for Switchable T
    Ma D; Shi M; Li X; Zhang J; Fan Y; Sun K; Jiang T; Peng C; Shi X
    Bioconjug Chem; 2020 Feb; 31(2):352-359. PubMed ID: 31693856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?
    Klenk C; Gawande R; Tran VT; Leung JT; Chi K; Owen D; Luna-Fineman S; Sakamoto KM; McMillan A; Quon A; Daldrup-Link HE
    J Nucl Med; 2016 Jan; 57(1):70-7. PubMed ID: 26471690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioinspired synthesis and characterization of gadolinium-labeled magnetite nanoparticles for dual contrast t1- and T2-weighted magnetic resonance imaging.
    Bae KH; Kim YB; Lee Y; Hwang J; Park H; Park TG
    Bioconjug Chem; 2010 Mar; 21(3):505-12. PubMed ID: 20166678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of portal perfusion abnormalities: comparison of 3 ferucarbotran-enhanced magnetic resonance imaging sequences.
    Iwazawa J; Nishida N; Yamamoto A; Nango M; Ninoi T; Murakami Y; Nakamura K; Inoue Y
    J Comput Assist Tomogr; 2006; 30(2):165-72. PubMed ID: 16628027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent.
    Maccioni F; Bruni A; Viscido A; Colaiacomo MC; Cocco A; Montesani C; Caprilli R; Marini M
    Radiology; 2006 Feb; 238(2):517-30. PubMed ID: 16371574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
    Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
    AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of t2-weighted magnetic resonance imaging early after myocardial infarction in dogs: comparison with bis-gadolinium-mesoporphyrin enhanced T1-weighted magnetic resonance imaging and functional data from cine magnetic resonance imaging.
    Dymarkowski S; Ni Y; Miao Y; Bogaert J; Rademakers F; Bosmans H; Marchal G
    Invest Radiol; 2002 Feb; 37(2):77-85. PubMed ID: 11799331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Core/shell Fe3O4/Gd2O3 nanocubes as T1-T2 dual modal MRI contrast agents.
    Li F; Zhi D; Luo Y; Zhang J; Nan X; Zhang Y; Zhou W; Qiu B; Wen L; Liang G
    Nanoscale; 2016 Jul; 8(25):12826-33. PubMed ID: 27297334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is there a need for contrast-enhanced T1-weighted MRI of the spine after inconspicuous short tau inversion recovery imaging?
    Mahnken AH; Wildberger JE; Adam G; Stanzel S; Schmitz-Rode T; Günther RW; Buecker A
    Eur Radiol; 2005 Jul; 15(7):1387-92. PubMed ID: 15776239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stomach diseases: MR evaluation using combined t2-weighted single-shot echo train spin-echo and gadolinium-enhanced spoiled gradient-echo sequences.
    Marcos HB; Semelka RC
    J Magn Reson Imaging; 1999 Dec; 10(6):950-60. PubMed ID: 10581508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.